Xortx receives no objection letter from health canada

Bridging pharmacokinetics study autosomal dominant polycystic kidney disease – xrx-008 program bridging pharmacokinetics study autosomal dominant polycystic kidney disease – xrx-008 program
XRTX Ratings Summary
XRTX Quant Ranking